Who Owns VRNA?

VERONA PHARMA PLC — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

Shares Outstanding

Institutional Holders

258

Total Inst. Value

$4.2B

% of Float Held

QoQ Holder Change

+166

Institutional data as of Q1 2025

New Positions

258

Closed Positions

0

Increased

0

Decreased

0

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1PERCEPTIVE ADVISORS LLCNew$416.7M6,563,340
2JANUS HENDERSON GROUP PLCNew$345.8M5,516,889
3Darwin Global Management, Ltd.New$246.0M3,923,204
4Frazier Life Sciences Management, L.P.New$219.5M3,457,850
5EVENTIDE ASSET MANAGEMENT, LLCNew$183.7M2,893,437
6RTW INVESTMENTS, LPNew$180.9M2,848,800
7NEA Management Company, LLCNew$170.7M2,688,565
8SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLCNew$147.5M2,323,115
9WELLINGTON MANAGEMENT GROUP LLPNew$135.3M2,131,502
10MAVERICK CAPITAL LTDNew$113.2M1,783,498

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue

Famous Fund Managers

Frequently Asked Questions

How many institutional investors hold VRNA?

As of Q1 2025, 258 institutional investors report holding VRNA (VERONA PHARMA PLC) in their 13F filings.

Which hedge fund owns the most VRNA?

The largest institutional holder of VRNA is PERCEPTIVE ADVISORS LLC with $416.7M in shares.

Are institutions buying or selling VRNA?

This quarter, 258 institutions opened new positions in VRNA and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.